{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:06:25Z","timestamp":1762160785835,"version":"3.44.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004965","name":"Sixth Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011103","name":"Sixth Framework Programme","doi-asserted-by":"publisher","award":["MYASTAID LSHM-CT-2006-037833"],"award-info":[{"award-number":["MYASTAID LSHM-CT-2006-037833"]}],"id":[{"id":"10.13039\/100011103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["MAR 02-0204"],"award-info":[{"award-number":["MAR 02-0204"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.2353\/ajpath.2009.090040","type":"journal-article","created":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T21:09:48Z","timestamp":1252616988000},"page":"1536-1544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The Effect of Plasma From Muscle-Specific Tyrosine Kinase Myasthenia Patients on Regenerating Endplates"],"prefix":"10.1016","volume":"175","author":[{"given":"W. Pascale","family":"ter Beek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Losen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc H.","family":"de Baets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel R.","family":"Wintzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik H.","family":"Niks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd G.","family":"van Duinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2009.090040_bib1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.2353\/ajpath.2009.090040_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0166-2236(83)90216-3","article-title":"Myasthenia gravis: immunobiology of a receptor disorder","volume":"6","author":"Drachman","year":"1983","journal-title":"Trends Neurosci"},{"key":"10.2353\/ajpath.2009.090040_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.2353\/ajpath.2009.090040_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1196\/annals.1405.034","article-title":"Treatment of myasthenia gravis by preventing acetylcholine receptor modulation","volume":"1132","author":"Losen","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.2353\/ajpath.2009.090040_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/274065a0","article-title":"Modulation of acetylcholine receptor in rat diaphragm by anti-receptor sera","volume":"274","author":"Heinemann","year":"1978","journal-title":"Nature"},{"issue":"Pt 7","key":"10.2353\/ajpath.2009.090040_bib6","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u201cseronegative\u201d myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.2353\/ajpath.2009.090040_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1749-6632.1987.tb51285.x","article-title":"Humoral pathogenesis of myasthenia gravis","volume":"505","author":"Drachman","year":"1987","journal-title":"Ann NY Acad Sci"},{"key":"10.2353\/ajpath.2009.090040_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity","volume":"1","author":"Mossman","year":"1986","journal-title":"Lancet"},{"key":"10.2353\/ajpath.2009.090040_bib9","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/mus.880171208","article-title":"Passive transfer of seronegative myasthenia gravis to mice","volume":"17","author":"Burges","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.2353\/ajpath.2009.090040_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2009.090040_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jnnp.2006.102517","article-title":"Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands","volume":"78","author":"Niks","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.2353\/ajpath.2009.090040_bib12","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.2353\/ajpath.2009.090040_bib13","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"10.2353\/ajpath.2009.090040_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/jnnp.2004.052415","article-title":"The features of myasthenia gravis with autoantibodies to MuSK","volume":"76","author":"Lavrnic","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.2353\/ajpath.2009.090040_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1196\/annals.1254.036","article-title":"Antibodies in myasthenia gravis and related disorders","volume":"998","author":"Vincent","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.2353\/ajpath.2009.090040_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.01.013","article-title":"Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1","volume":"195","author":"Niks","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2009.090040_bib17","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"10.2353\/ajpath.2009.090040_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/377232a0","article-title":"Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice","volume":"377","author":"Gautam","year":"1995","journal-title":"Nature"},{"key":"10.2353\/ajpath.2009.090040_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1101\/SQB.1990.055.01.041","article-title":"The agrin hypothesis","volume":"55","author":"McMahan","year":"1990","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.2353\/ajpath.2009.090040_bib20","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1242\/dev.02696","article-title":"LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction","volume":"133","author":"Weatherbee","year":"2006","journal-title":"Development"},{"key":"10.2353\/ajpath.2009.090040_bib21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for Agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"10.2353\/ajpath.2009.090040_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell"},{"key":"10.2353\/ajpath.2009.090040_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.embor.7400065","article-title":"Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference","volume":"5","author":"Kong","year":"2004","journal-title":"EMBO Rep"},{"key":"10.2353\/ajpath.2009.090040_bib24","doi-asserted-by":"crossref","first-page":"9924","DOI":"10.1073\/pnas.171539698","article-title":"Neural agrin controls acetylcholine receptor stability in skeletal muscle fibers","volume":"98","author":"Bezakova","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.090040_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1113\/jphysiol.1991.sp018758","article-title":"Neuromuscular transmission at newly formed neuromuscular junctions in the regenerating soleus muscle of the rat","volume":"441","author":"Grubb","year":"1991","journal-title":"J Physiol"},{"key":"10.2353\/ajpath.2009.090040_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2009.090040_bib27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2009.090040_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(91)90413-K","article-title":"A nonimmunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction","volume":"196","author":"Molenaar","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.2353\/ajpath.2009.090040_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2008.05.027","article-title":"A relative weak leg muscle in the rolling Nagoya mouse as a model for Lambert-Eaton myasthenic syndrome","volume":"201\u2013202","author":"Molenaar","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2009.090040_bib30","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/brain\/awh612","article-title":"Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis","volume":"128","author":"Losen","year":"2005","journal-title":"Brain"},{"key":"10.2353\/ajpath.2009.090040_bib31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2353\/ajpath.2007.060676","article-title":"Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis","volume":"170","author":"Martinez-Martinez","year":"2007","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2009.090040_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00307202","article-title":"Ultrastructural study of experimental muscle degeneration and regeneration in the adult rat","volume":"131","author":"Jirmanova","year":"1972","journal-title":"Z Zellforsch Mikrosk Anat"},{"key":"10.2353\/ajpath.2009.090040_bib33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","article-title":"Safety factor at the neuromuscular junction","volume":"64","author":"Wood","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.2353\/ajpath.2009.090040_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1196\/annals.1254.005","article-title":"Transmitter release deficits at the neuromuscular synapse of mice with mutations in the Cav2.1 (\u03b11A) subunit of the P\/Q-type Ca2+ channel","volume":"998","author":"Plomp","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.2353\/ajpath.2009.090040_bib35","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1523\/JNEUROSCI.4130-07.2008","article-title":"Muscle-specific receptor tyrosine kinase endocytosis in acetylcholine receptor clustering in response to agrin","volume":"28","author":"Zhu","year":"2008","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2009.090040_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0301-0082(85)90018-8","article-title":"Nicotinic acetylcholine receptors in vertebrate muscle: properties, distribution and neural control","volume":"25","author":"Salpeter","year":"1985","journal-title":"Prog Neurobiol"},{"key":"10.2353\/ajpath.2009.090040_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/dna.1994.13.9","article-title":"Molecular cloning and functional analysis of the promoter of rat skeletal muscle voltage-sensitive sodium channel subtype 2 (rSkM2): evidence for muscle-specific nuclear protein binding to the core promoter","volume":"13","author":"Sheng","year":"1994","journal-title":"DNA Cell Biol"},{"key":"10.2353\/ajpath.2009.090040_bib38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1083\/jcb.108.2.647","article-title":"Degradation rate of acetylcholine receptors inserted into denervated vertebrate neuromuscular junctions","volume":"108","author":"Shyng","year":"1989","journal-title":"J Cell Biol"},{"key":"10.2353\/ajpath.2009.090040_bib39","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1523\/JNEUROSCI.10-12-03905.1990","article-title":"Effect of reinnervation on the degradation rate of junctional acetylcholine receptors synthesized in denervated skeletal muscles","volume":"10","author":"Shyng","year":"1990","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2009.090040_bib40","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/hmg\/ddh333","article-title":"MUSK, a new target for mutations causing congenital myasthenic syndrome","volume":"13","author":"Chevessier","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.2353\/ajpath.2009.090040_bib41","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00374570","article-title":"Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671\/RD cell line","volume":"428","author":"Barrett-Jolley","year":"1994","journal-title":"Pflugers Arch"},{"key":"10.2353\/ajpath.2009.090040_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2007.01.010","article-title":"Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures","volume":"185","author":"Farrugia","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2009.090040_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2006.03.016","article-title":"Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)","volume":"175","author":"Jha","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2009.090040_bib44","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2009.090040_bib45","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1523\/JNEUROSCI.10-08-02660.1990","article-title":"Neuromuscular junctions shrink and expand as muscle fiber size is manipulated: in vivo observations in the androgen-sensitive bulbocavernosus muscle of mice","volume":"10","author":"Balice-Gordon","year":"1990","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2009.090040_bib46","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1523\/JNEUROSCI.07-04-01215.1987","article-title":"Visualization of neuromuscular junctions over periods of several months in living mice","volume":"7","author":"Lichtman","year":"1987","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2009.090040_bib47","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/01.WNL.0000128048.23930.1D","article-title":"Are MuSK antibodies the primary cause of myasthenic symptoms?","volume":"62","author":"Selcen","year":"2004","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2009.090040_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ana.20341","article-title":"Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis","volume":"57","author":"Shiraishi","year":"2005","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2009.090040_bib49","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.WNL.0000129702.41868.A5","article-title":"Is \u201cseronegative\u201d MG explained by autoantibodies to MuSK?","volume":"62","author":"Lindstrom","year":"2004","journal-title":"Neurology"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010606657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010606657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:06:00Z","timestamp":1757599560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010606657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0002944010606657"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2009.090040","relation":{},"ISSN":["0002-9440"],"issn-type":[{"type":"print","value":"0002-9440"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Plasma From Muscle-Specific Tyrosine Kinase Myasthenia Patients on Regenerating Endplates","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2009.090040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}